CPHI vs SRPT · rev $4.1M vs rev $1.90B
China Pharma Holdings Inc (CPHI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
CPHI currently screens at market cap $29.0M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CPHI and SRPT stock pages for the full models.
Not investment advice.